Skip to Content

Logo 2900 (Glipizide extended release 10 mg)

Pill with imprint Logo 2900 is White, Round and has been identified as Glipizide extended release 10 mg. It is supplied by Actavis.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2900

Glipizide extended release 10 mg Logo 2900 Front
Glipizide extended release 10 mg Logo 2900 Back

Glipizide extended release

Imprint
Logo 2900
Strength
10 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis
National Drug Code (NDC)
00228-2900
Inactive Ingredients
acetyltributyl citrate, hydroxyethyl cellulose (140 cps at 5%), hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.